Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase 2, Double-blind, Active-controlled, Dose-titrating Efficacy and Safety Study of Firibastat Compared to Ramipril Administered Orally, Twice Daily, Over 12 Weeks to Prevent Left Ventricular Dysfunction After Acute MI

Next Previous
Search
Trial Profile

A Phase 2, Double-blind, Active-controlled, Dose-titrating Efficacy and Safety Study of Firibastat Compared to Ramipril Administered Orally, Twice Daily, Over 12 Weeks to Prevent Left Ventricular Dysfunction After Acute MI

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 01 Mar 2023

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Firibastat (Primary) ; Ramipril
  • Indications Heart failure; Left ventricular dysfunction; Myocardial infarction
  • Focus Therapeutic Use
  • Acronyms QUORUM
  • Sponsors Quantum Genomics

    • Most Recent Events

    • 14 Feb 2023 Status changed to completed, according to Results published in the American Journal of Cardiovascular Drugs
    • 09 Feb 2023 Primary endpoint has not been met (Left ventricular ejection fraction assessed by cardiac magnetic resonance imaging (CMRI)) , according to Results published in the American Journal of Cardiovascular Drugs
    • 09 Feb 2023 Results published in the American Journal of Cardiovascular Drugs

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top